Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seagen Inc. (SGEN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seagen Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1060736.
Total stock buying since 2014: $1,160,479,679.
Total stock sales since 2014: $1,004,689,522.
Total stock option exercises since 2014: $71,753,696.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 392,914 | $73,193,732 | 322,898 | $16,265,420 |
| 2022 | 0 | $0 | 250,716 | $37,014,358 | 234,844 | $7,144,665 |
| 2021 | 0 | $0 | 968,655 | $156,502,918 | 465,023 | $11,080,930 |
| 2020 | 0 | $0 | 3,776,313 | $607,190,520 | 685,142 | $14,851,091 |
| 2019 | 0 | $0 | 532,740 | $44,228,990 | 430,833 | $6,089,430 |
| 2018 | 5,306,804 | $275,895,222 | 375,703 | $24,277,576 | 373,126 | $4,469,898 |
| 2017 | 0 | $0 | 425,707 | $24,086,518 | 375,862 | $4,731,181 |
| 2016 | 6,200,638 | $257,974,072 | 373,779 | $18,628,401 | 407,265 | $4,207,373 |
| 2015 | 9,422,008 | $389,855,263 | 381,027 | $15,900,526 | 277,285 | $2,245,552 |
| 2014 | 7,019,620 | $236,755,122 | 89,351 | $3,665,983 | 86,333 | $668,156 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-11 | 0 | $0 | 19,405 | $4,138,598 | 0 | $0 |
| 2023-09 | 0 | $0 | 9,125 | $1,877,810 | 8,785 | $387,330 |
| 2023-08 | 0 | $0 | 18,034 | $3,740,225 | 1,812 | $245,761 |
| 2023-07 | 0 | $0 | 708 | $136,261 | 0 | $0 |
| 2023-06 | 0 | $0 | 16,215 | $3,166,578 | 16,215 | $665,463 |
| 2023-05 | 0 | $0 | 29,245 | $5,847,359 | 35,025 | $2,384,769 |
| 2023-04 | 0 | $0 | 102,470 | $20,885,402 | 87,869 | $4,517,045 |
| 2023-03 | 0 | $0 | 91,405 | $16,949,657 | 79,496 | $3,413,593 |
| 2023-02 | 0 | $0 | 75,729 | $12,326,160 | 63,696 | $2,807,160 |
| 2023-01 | 0 | $0 | 30,578 | $4,125,682 | 30,000 | $1,844,299 |
| 2022-12 | 0 | $0 | 1,129 | $144,094 | 8,750 | $321,125 |
| 2022-11 | 0 | $0 | 15,833 | $2,060,276 | 9,634 | $384,982 |
| 2022-10 | 0 | $0 | 10,000 | $1,350,000 | 10,000 | $731,400 |
| 2022-08 | 0 | $0 | 46,056 | $7,287,930 | 0 | $0 |
| 2022-07 | 0 | $0 | 712 | $127,775 | 0 | $0 |
| 2022-06 | 0 | $0 | 35,769 | $6,415,740 | 20,878 | $1,332,070 |
| 2022-05 | 0 | $0 | 28,242 | $3,682,594 | 27,909 | $728,424 |
| 2022-04 | 0 | $0 | 26,228 | $3,957,572 | 21,043 | $525,062 |
| 2022-03 | 0 | $0 | 29,043 | $3,822,228 | 89,043 | $1,961,122 |
| 2022-02 | 0 | $0 | 22,985 | $3,201,954 | 21,543 | $535,092 |
| 2022-01 | 0 | $0 | 34,719 | $4,964,195 | 26,044 | $625,388 |
| 2021-12 | 0 | $0 | 142,976 | $22,424,631 | 45,449 | $1,186,218 |
| 2021-11 | 0 | $0 | 382,552 | $63,555,459 | 87,037 | $3,459,146 |
| 2021-10 | 0 | $0 | 33,564 | $6,041,520 | 33,564 | $1,377,466 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-10 | Epstein David R (CEO) | Sale | 10,620 | 213.01 | 2,262,166 |
| 2023-11-09 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,785 | 213.59 | 1,876,432 |
| 2023-09-21 | Romp Charles R (EVP, Commercial U.S.) | Sale | 45 | 206.50 | 9,292 |
| 2023-09-21 | Dansey Roger D (President, R&D & CMO) | Sale | 71 | 206.50 | 14,661 |
| 2023-09-21 | Himes Vaughn B (Chief Technical Officer) | Sale | 80 | 206.50 | 16,520 |
| 2023-09-21 | Liu Jean I (Chief Legal Officer) | Sale | 64 | 206.50 | 13,216 |
| 2023-09-21 | Simpson Todd E (Chief Financial Officer) | Sale | 80 | 206.50 | 16,520 |
| 2023-09-07 | Himes Vaughn B (Chief Technical Officer) | Sale | 8,785 | 205.76 | 1,807,601 |
| 2023-09-07 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 8,785 | 44.09 | 387,330 |
| 2023-08-31 | Romp Charles R (EVP, Commercial U.S.) | Sale | 555 | 206.97 | 114,866 |
| 2023-08-31 | Dansey Roger D (President, R&D & CMO) | Sale | 4,029 | 206.97 | 833,866 |
| 2023-08-31 | Himes Vaughn B (Chief Technical Officer) | Sale | 1,795 | 206.97 | 371,503 |
| 2023-08-31 | Liu Jean I (Chief Legal Officer) | Sale | 1,893 | 206.97 | 391,786 |
| 2023-08-31 | Simpson Todd E (Chief Financial Officer) | Sale | 2,122 | 206.97 | 439,181 |
| 2023-08-29 | Romp Charles R (EVP, Commercial U.S.) | Sale | 438 | 206.00 | 90,228 |
| 2023-08-29 | Dansey Roger D (President, R&D & CMO) | Sale | 1,016 | 206.00 | 209,296 |
| 2023-08-29 | Himes Vaughn B (Chief Technical Officer) | Sale | 371 | 206.00 | 76,426 |
| 2023-08-29 | Liu Jean I (Chief Legal Officer) | Sale | 405 | 206.00 | 83,430 |
| 2023-08-29 | Simpson Todd E (Chief Financial Officer) | Sale | 485 | 206.00 | 99,910 |
| 2023-08-28 | Welch Daniel G (Director) | Sale | 4,925 | 209.08 | 1,029,733 |
| 2023-08-28 | Welch Daniel G (Director) | Option Ex | 1,812 | 135.63 | 245,761 |
| 2023-07-03 | Romp Charles R (EVP, Commercial U.S.) | Sale | 708 | 192.46 | 136,261 |
| 2023-06-07 | Himes Vaughn B (Chief Technical Officer) | Sale | 16,215 | 195.29 | 3,166,578 |
| 2023-06-07 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 16,215 | 41.04 | 665,463 |
| 2023-05-16 | Romp Charles R (EVP, Commercial U.S.) | Sale | 349 | 189.86 | 66,260 |
| 2023-05-15 | Welch Daniel G (Director) | Sale | 1,864 | 200.02 | 372,837 |
| 2023-05-15 | Welch Daniel G (Director) | Option Ex | 1,864 | 135.63 | 252,814 |
| 2023-05-02 | Welch Daniel G (Director) | Sale | 14,707 | 200.07 | 2,942,400 |
| 2023-05-02 | Welch Daniel G (Director) | Option Ex | 8,521 | 124.07 | 1,057,200 |
| 2023-05-01 | Baker Bros. Advisors (gp) Llc (Director) | Option Ex | 17,500 | 36.70 | 642,250 |
| 2023-05-01 | Welch Daniel G (Director) | Sale | 12,325 | 200.07 | 2,465,862 |
| 2023-05-01 | Welch Daniel G (Director) | Option Ex | 7,140 | 60.58 | 432,505 |
| 2023-04-17 | Dansey Roger D (President, R&D & CMO) | Sale | 10,000 | 205.95 | 2,059,490 |
| 2023-04-17 | Dansey Roger D (President, R&D & CMO) | Option Ex | 10,000 | 72.64 | 726,400 |
| 2023-04-17 | Liu Jean I (Chief Legal Officer) | Sale | 5,000 | 205.86 | 1,029,310 |
| 2023-04-17 | Liu Jean I (Chief Legal Officer) | Option Ex | 5,000 | 39.15 | 195,750 |
| 2023-04-10 | Simpson Todd E (Chief Financial Officer) | Sale | 55,344 | 204.44 | 11,314,527 |
| 2023-04-10 | Simpson Todd E (Chief Financial Officer) | Option Ex | 55,344 | 46.37 | 2,566,301 |
| 2023-04-06 | Romp Charles R (EVP, Commercial U.S.) | Sale | 133 | 205.86 | 27,378 |
| 2023-04-06 | Dansey Roger D (President, R&D & CMO) | Sale | 333 | 205.86 | 68,550 |
| 2023-04-06 | Himes Vaughn B (Chief Technical Officer) | Sale | 243 | 205.86 | 50,023 |
| 2023-04-06 | Liu Jean I (Chief Legal Officer) | Sale | 174 | 205.86 | 35,819 |
| 2023-04-06 | Simpson Todd E (Chief Financial Officer) | Sale | 243 | 205.86 | 50,023 |
| 2023-04-03 | Welch Daniel G (Director) | Sale | 31,000 | 201.62 | 6,250,282 |
| 2023-04-03 | Welch Daniel G (Director) | Option Ex | 17,525 | 58.69 | 1,028,594 |
| 2023-03-16 | Liu Jean I (Chief Legal Officer) | Sale | 5,000 | 199.90 | 999,500 |
| 2023-03-16 | Liu Jean I (Chief Legal Officer) | Option Ex | 5,000 | 39.15 | 195,750 |
| 2023-03-14 | Welch Daniel G (Director) | Sale | 832 | 200.00 | 166,400 |
| 2023-03-14 | Welch Daniel G (Director) | Option Ex | 470 | 38.82 | 18,245 |
| 2023-03-13 | Welch Daniel G (Director) | Sale | 26,565 | 201.24 | 5,345,993 |
| 2023-03-13 | Welch Daniel G (Director) | Option Ex | 15,018 | 39.66 | 595,613 |
| 2023-03-09 | Simpson Todd E (Chief Financial Officer) | Sale | 42,793 | 176.66 | 7,559,683 |
| 2023-03-09 | Simpson Todd E (Chief Financial Officer) | Option Ex | 42,793 | 45.30 | 1,938,522 |
| 2023-03-02 | Himes Vaughn B (Chief Technical Officer) | Sale | 16,215 | 177.50 | 2,878,081 |
| 2023-03-02 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 16,215 | 41.04 | 665,463 |
| 2023-02-27 | Simpson Todd E (Chief Financial Officer) | Sale | 20,000 | 182.53 | 3,650,600 |
| 2023-02-16 | Liu Jean I (Chief Legal Officer) | Sale | 5,000 | 155.00 | 775,000 |
| 2023-02-16 | Liu Jean I (Chief Legal Officer) | Option Ex | 5,000 | 39.15 | 195,750 |
| 2023-02-16 | Simpson Todd E (Chief Financial Officer) | Sale | 39,946 | 160.00 | 6,391,399 |
| 2023-02-16 | Simpson Todd E (Chief Financial Officer) | Option Ex | 39,946 | 39.15 | 1,563,885 |
| 2023-02-15 | Dansey Roger D (President, R&D & CMO) | Sale | 10,000 | 140.07 | 1,400,700 |
| 2023-02-15 | Dansey Roger D (President, R&D & CMO) | Option Ex | 10,000 | 72.64 | 726,400 |
| 2023-02-13 | Gryska David W (Director) | Option Ex | 8,750 | 36.70 | 321,125 |
| 2023-02-02 | Dansey Roger D (President, R&D & CMO) | Sale | 783 | 138.52 | 108,461 |
| 2023-01-24 | Dansey Roger D (President, R&D & CMO) | Sale | 10,000 | 135.00 | 1,350,000 |
| 2023-01-24 | Dansey Roger D (President, R&D & CMO) | Option Ex | 10,000 | 72.64 | 726,400 |
| 2023-01-24 | Liu Jean I (Chief Legal Officer) | Sale | 5,000 | 135.03 | 675,134 |
| 2023-01-24 | Liu Jean I (Chief Legal Officer) | Option Ex | 5,000 | 39.15 | 195,750 |
| 2023-01-17 | Liu Jean I (Chief Legal Officer) | Sale | 578 | 130.71 | 75,548 |
| 2023-01-05 | Dansey Roger D (President R&D & CMO) | Sale | 7,500 | 135.00 | 1,012,500 |
| 2023-01-05 | Dansey Roger D (President R&D & CMO) | Option Ex | 7,500 | 72.64 | 544,800 |
| 2023-01-05 | Liu Jean I (Chief Legal Officer) | Sale | 4,525 | 135.00 | 610,875 |
| 2023-01-05 | Liu Jean I (Chief Legal Officer) | Option Ex | 4,525 | 39.15 | 177,153 |
| 2023-01-04 | Dansey Roger D (President R&D & CMO) | Sale | 2,500 | 135.00 | 337,500 |
| 2023-01-04 | Dansey Roger D (President R&D & CMO) | Option Ex | 2,500 | 72.64 | 181,600 |
| 2023-01-04 | Liu Jean I (Chief Legal Officer) | Sale | 475 | 135.00 | 64,125 |
| 2023-01-04 | Liu Jean I (Chief Legal Officer) | Option Ex | 475 | 39.15 | 18,596 |
| 2022-12-20 | Romp Charles R (EVP, Commercial U.S.) | Sale | 1,129 | 127.63 | 144,094 |
| 2022-12-12 | Simonian Nancy A (Director) | Option Ex | 8,750 | 36.70 | 321,125 |
| 2022-11-17 | Liu Jean I (Chief Legal Officer) | Sale | 8,333 | 131.05 | 1,092,056 |
| 2022-11-17 | Liu Jean I (Chief Legal Officer) | Option Ex | 8,333 | 34.20 | 284,988 |
| 2022-11-14 | Liu Jean I (Chief Legal Officer) | Option Ex | 1,301 | 76.86 | 99,994 |
| 2022-11-11 | Gryska David W (Director) | Sale | 7,500 | 129.10 | 968,220 |
| 2022-10-17 | Dansey Roger D (Interim CEO & CMO) | Sale | 10,000 | 135.00 | 1,350,000 |
| 2022-10-17 | Dansey Roger D (Interim CEO & CMO) | Option Ex | 10,000 | 73.14 | 731,400 |
| 2022-08-31 | Romp Charles R (EVP, Commercial) | Sale | 1,133 | 154.41 | 174,952 |
| 2022-08-31 | Dansey Roger D (Interim CEO & CMO) | Sale | 10,038 | 154.41 | 1,550,016 |
| 2022-08-31 | Himes Vaughn B (Chief Technical Officer) | Sale | 3,584 | 154.41 | 553,423 |
| 2022-08-31 | Liu Jean I (Chief Legal Officer) | Sale | 7,296 | 154.41 | 1,126,610 |
| 2022-08-31 | Simpson Todd E (Chief Financial Officer) | Sale | 4,186 | 154.41 | 646,381 |
| 2022-08-16 | Romp Charles R (EVP, Commercial) | Sale | 1,765 | 170.22 | 300,429 |
| 2022-08-16 | Dansey Roger D (Interim CEO & CMO) | Sale | 4,254 | 170.22 | 724,094 |
| 2022-08-16 | Himes Vaughn B (Chief Technical Officer) | Sale | 1,527 | 170.22 | 259,918 |
| 2022-08-16 | Liu Jean I (Chief Legal Officer) | Sale | 1,639 | 170.22 | 278,982 |
| 2022-08-16 | Simpson Todd E (Chief Financial Officer) | Sale | 1,967 | 170.22 | 334,812 |
| 2022-07-05 | Romp Charles R (EVP, Commercial) | Sale | 712 | 179.46 | 127,775 |
| 2022-06-28 | Dansey Roger D (Chief Medical Officer) | Sale | 34,635 | 180.00 | 6,234,300 |
| 2022-06-28 | Dansey Roger D (Chief Medical Officer) | Option Ex | 19,744 | 65.11 | 1,285,531 |
| 2022-06-17 | Himes Vaughn B (Chief Technical Officer) | Sale | 1,134 | 160.00 | 181,440 |
| 2022-06-17 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 1,134 | 41.04 | 46,539 |
| 2022-05-24 | Himes Vaughn B (Chief Technical Officer) | Sale | 10,866 | 137.51 | 1,494,151 |
| 2022-05-24 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 10,866 | 26.10 | 283,602 |
| 2022-05-16 | Romp Charles R (EVP, Commercial) | Sale | 333 | 134.21 | 44,690 |
| 2022-05-12 | Siegall Clay B (President & CEO) | Sale | 17,043 | 125.78 | 2,143,753 |
| 2022-05-12 | Siegall Clay B (President & CEO) | Option Ex | 17,043 | 26.10 | 444,822 |
| 2022-04-21 | Dansey Roger D (Chief Medical Officer) | Sale | 652 | 144.15 | 93,985 |
| 2022-04-20 | Romp Charles R (EVP, Commercial) | Sale | 319 | 144.32 | 46,037 |
| 2022-04-20 | Dansey Roger D (Chief Medical Officer) | Sale | 787 | 144.32 | 113,579 |
| 2022-04-20 | Himes Vaughn B (Chief Technical Officer) | Sale | 574 | 144.32 | 82,839 |
| 2022-04-20 | Liu Jean I (Chief Legal Officer) | Sale | 401 | 144.32 | 57,871 |
| 2022-04-20 | Simpson Todd E (Chief Financial Officer) | Sale | 567 | 144.32 | 81,828 |
| 2022-04-20 | Siegall Clay B (President & CEO) | Sale | 1,885 | 144.32 | 272,041 |
| 2022-04-19 | Gryska David W (Director) | Sale | 4,000 | 144.19 | 576,760 |
| 2022-04-19 | Gryska David W (Director) | Option Ex | 4,000 | 20.06 | 80,240 |
| 2022-04-07 | Siegall Clay B (President and CEO) | Sale | 17,043 | 154.47 | 2,632,632 |
| 2022-04-07 | Siegall Clay B (President and CEO) | Option Ex | 17,043 | 26.10 | 444,822 |
| 2022-03-08 | Baker Bros. Advisors (gp) Llc (Director) | Option Ex | 35,000 | 20.06 | 702,100 |
| 2022-03-07 | Siegall Clay B (President & CEO) | Sale | 17,043 | 134.62 | 2,294,328 |
| 2022-03-07 | Siegall Clay B (President & CEO) | Option Ex | 17,043 | 26.10 | 444,822 |
| 2022-03-03 | Himes Vaughn B (Chief Technical Officer) | Sale | 12,000 | 127.33 | 1,527,900 |
| 2022-03-03 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 12,000 | 26.10 | 313,200 |
| 2022-03-02 | Simonian Nancy A (Director) | Option Ex | 25,000 | 20.04 | 501,000 |
| 2022-02-07 | Gryska David W (Director) | Sale | 4,500 | 138.51 | 623,295 |
| 2022-02-07 | Gryska David W (Director) | Option Ex | 4,500 | 20.06 | 90,270 |
| 2022-02-07 | Siegall Clay B (President & CEO) | Sale | 17,043 | 139.72 | 2,381,282 |
| 2022-02-07 | Siegall Clay B (President & CEO) | Option Ex | 17,043 | 26.10 | 444,822 |
| 2022-02-03 | Dansey Roger D (Chief Medical Officer) | Sale | 703 | 136.14 | 95,706 |
| 2022-02-02 | Dansey Roger D (Chief Medical Officer) | Sale | 739 | 137.58 | 101,671 |
| 2022-01-28 | Gryska David W (Director) | Sale | 4,500 | 122.94 | 553,207 |
| 2022-01-28 | Gryska David W (Director) | Option Ex | 4,500 | 20.06 | 90,270 |
| 2022-01-14 | Gryska David W (Director) | Sale | 4,500 | 135.24 | 608,580 |
| 2022-01-14 | Gryska David W (Director) | Option Ex | 4,500 | 20.06 | 90,270 |
| 2022-01-07 | Siegall Clay B (President & CEO) | Sale | 17,044 | 145.43 | 2,478,760 |
| 2022-01-07 | Siegall Clay B (President & CEO) | Option Ex | 17,044 | 26.10 | 444,848 |
| 2022-01-03 | Dansey Roger D (Chief Medical Officer) | Sale | 8,675 | 152.58 | 1,323,648 |
| 2021-12-21 | Dansey Roger D (Chief Medical Officer) | Sale | 280 | 155.58 | 43,562 |
| 2021-12-20 | Romp Charles R (EVP, Commercial) | Sale | 1,323 | 149.85 | 198,251 |
| 2021-12-20 | Dansey Roger D (Chief Medical Officer) | Sale | 280 | 149.85 | 41,958 |
| 2021-12-20 | Himes Vaughn B (Chief Technical Officer) | Sale | 345 | 149.85 | 51,698 |
| 2021-12-20 | Liu Jean I (Chief Legal Officer) | Sale | 276 | 149.85 | 41,358 |
| 2021-12-20 | Simpson Todd E (Chief Financial Officer) | Sale | 345 | 149.85 | 51,698 |
| 2021-12-20 | Siegall Clay B (President & CEO) | Sale | 1,227 | 149.85 | 183,865 |
| 2021-12-07 | Siegall Clay B (President & CEO) | Sale | 45,449 | 148.52 | 6,749,903 |
| 2021-12-07 | Siegall Clay B (President & CEO) | Option Ex | 45,449 | 26.10 | 1,186,218 |
| 2021-12-01 | Baker Brothers Life Sciences Lp | Sale | 93,451 | 161.18 | 15,062,338 |
| 2021-11-30 | Baker Brothers Life Sciences Lp | Sale | 301,444 | 162.21 | 48,896,628 |
| 2021-11-11 | Himes Vaughn B (Chief Technical Officer) | Sale | 6,000 | 178.87 | 1,073,202 |
| 2021-11-11 | Himes Vaughn B (Chief Technical Officer) | Option Ex | 6,000 | 26.10 | 156,600 |
| 2021-11-04 | Liu Jean I (GC/EVP, Leg Affairs) | Option Ex | 1,617 | 46.37 | 74,980 |
| 2021-11-04 | Simpson Todd E (Chief Financial Officer) | Option Ex | 2,156 | 46.37 | 99,973 |
Insider trading activities including stock purchases, stock sales, and option exercises of SGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seagen Inc. (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.